Exane Derivatives’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,095
| Closed | -$2.68M | – | 782 |
|
|
2022
Q1 | $2.68M | Buy |
11,095
+7,551
| +213% | +$1.73M | 0.76% | 20 |
|
|
2021
Q4 | $797K | Buy |
3,544
+3,169
| +845% | +$669K | 0.19% | 112 |
|
|
2021
Q3 | $79.7K | Buy |
375
+371
| +9,275% | +$85.4K | 0.02% | 561 |
|
|
2021
Q2 | $979 | Buy |
+4
| New | +$984 | ﹤0.01% | 878 |
|
|
2021
Q1 | – | Sell |
-749
| Closed | -$172K | – | 905 |
|
|
2020
Q4 | $172K | Buy |
749
+226
| +43% | +$52.1K | 0.05% | 330 |
|
|
2020
Q3 | $133K | Sell |
523
-9,047
| -95% | -$2.24M | 0.04% | 253 |
|
|
2020
Q2 | $2.26M | Buy |
9,570
+8,969
| +1,492% | +$2.05M | 0.6% | 42 |
|
|
2020
Q1 | $122K | Hold |
601
| – | – | 0.03% | 261 |
|
|
2019
Q4 | $145K | Sell |
601
-147
| -20% | -$32.4K | 0.03% | 281 |
|
|
2019
Q3 | $145K | Hold |
748
| – | – | 0.03% | 285 |
|
|
2019
Q2 | $138K | Buy |
+748
| New | +$134K | 0.02% | 293 |
|
|
2019
Q1 | – | Sell |
-516
| Closed | -$100K | – | 655 |
|
|
2018
Q4 | $100K | Hold |
516
| – | – | 0.02% | 321 |
|
|
2018
Q3 | $107K | Sell |
516
-4,172
| -89% | -$822K | 0.02% | 309 |
|
|
2018
Q2 | $865K | Buy |
4,688
+113
| +2% | +$20K | 0.14% | 136 |
|
|
2018
Q1 | $780K | Buy |
4,575
+622
| +16% | +$114K | 0.16% | 137 |
|
|
2017
Q4 | $687K | Buy |
3,953
+3,553
| +888% | +$629K | 0.12% | 139 |
|
|
2017
Q3 | $74.6K | Sell |
400
-921
| -70% | -$163K | 0.01% | 284 |
|
|
2017
Q2 | $227K | Buy |
1,321
+1,320
| +132,000% | +$215K | 0.05% | 197 |
|
|
2017
Q1 | $164 | Hold |
1
| – | – | ﹤0.01% | 471 |
|
|
2016
Q4 | $146 | Sell |
1
-47,627
| -100% | -$7.17M | ﹤0.01% | 522 |
|
|
2016
Q3 | $7.94M | Buy |
+47,628
| New | +$8.05M | 1.19% | 29 |
|
|
2016
Q2 | – | Sell |
-372
| Closed | -$55.8K | – | 553 |
|
|
2016
Q1 | $55.8K | Buy |
+372
| New | +$55.3K | 0.01% | 295 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$138 | – | 512 |
|
|
2015
Q3 | $138 | Hold |
1
| – | – | ﹤0.01% | 476 |
|
|
2015
Q2 | $154 | Hold |
1
| – | – | ﹤0.01% | 479 |
|
|
2015
Q1 | $160 | Sell |
1
-603
| -100% | -$95K | ﹤0.01% | 479 |
|
|
2014
Q4 | $96.2K | Buy |
+604
| New | +$94.1K | 0.01% | 286 |
|
Other funds holding AMGN
Exane Derivatives's AMGN Position: Q2 2022 in Review
Exane Derivatives sold out of Amgen (AMGN) in Q2 2022, closing a stake of 11,095 shares — an estimated $2.68M sold.
Exane Derivatives first reported a position in AMGN in Q4 2014 and held it in 26 quarters. The position peaked at $7.94M in Q3 2016. 2,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.
- Exane Derivatives reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 11,095 Amgen shares in Q2 2022, an estimated $2.68M.
- Exane Derivatives first reported a position in Amgen in Q4 2014 and held it in 26 quarters.
- Exane Derivatives's Amgen position peaked at $7.94M in Q3 2016.
- 2,353 funds tracked by Wall St. Rank held Amgen as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.